$AZN
AstraZeneca PLC
XNYS•Health Care•Pharmaceutical Preparations
$166.56
▲+0.25%+$0.424
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is AZN up today? It is at $166.56 (+0.25%), and our scanner flagged it 71 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AZN spikes, and full due diligence on AZN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AZN 71 times in the last 30 days. Create a free account to track $AZN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AZN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AZN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sharma Mani Officer | Acquired (grant/award) | +1 | added <0.1% | 19K | $163 at $162.60 | Sep 8, 26 |
Sharma Mani Officer | Bought (open market) | +20 | added 0.1% | 19K | $3K at $160.57 | Aug 8, 26 |
Sharma Mani Officer | Acquired (grant/award) | +2 | added <0.1% | 19K | $327 at $163.34 | Aug 6, 26 |
Sharma Mani Officer | Acquired (grant/award) | +2 | added <0.1% | 19K | $381 at $190.43 | Jul 6, 26 |
Sharma Mani Officer | Acquired (grant/award) | +1 | added <0.1% | 19K | $180 at $179.75 | Jun 8, 26 |
Sharma Mani Officer | Sold (automatic/other) | -12K | sold 38% | 19K | $2.2M at $185.78 | May 20, 26 |
Sharma Mani Officer | Acquired (grant/award) | +1 | added <0.1% | 31K | $186 at $186.28 | May 6, 26 |
Sharma Mani Officer | Acquired (grant/award) | +1 | added <0.1% | 31K | $196 at $196.03 | Apr 7, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AZN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AZN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AZN last traded at $166.56, up 0.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
AstraZeneca PLC (AZN) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. AZN currently has a dividend yield of about 0.96% ($1.59 per share per year). Dividend figures can change; this is not investment advice.
The AZN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AZN 71 times in the last 30 days.
AZN (AstraZeneca PLC) trades on XNYS, with a market cap of about $257.57B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AZN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AZN discussion
Sign in to ask a question or join the discussion.